Hikaru Sasaki
Affiliations: | Neurosurgery | Keio University, Tokyo, Minato-ku, Tōkyō-to, Japan |
Area:
Chemotherapy, Brain TumorWebsite:
http://web.sc.itc.keio.ac.jp/ns/eng/ikyoku_eng/index_staff_eng.htmlGoogle:
"Hikaru Sasaki"Cross-listing: Neurotree - Neuro-oncology Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sasaki H. (2023) [Meningioma]. No Shinkei Geka. Neurological Surgery. 51: 829-836 |
Tamura R, Iwanami A, Ohara K, et al. (2023) Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain Tumor Pathology |
Pareira ES, Shibuya M, Ohara K, et al. (2022) The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas. Brain Tumor Pathology. 39: 79-87 |
Kanazawa T, Ohara K, Kitamura Y, et al. (2021) Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy. Journal of Neuro-Oncology |
Kumon M, Nakae S, Murayama K, et al. (2021) Myoinositol to Total Choline Ratio in Glioblastomas as a Potential Prognostic Factor in Preoperative Magnetic Resonance Spectroscopy. Neurologia Medico-Chirurgica |
Arita H, Matsushita Y, Machida R, et al. (2020) TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Acta Neuropathologica Communications. 8: 201 |
Kanazawa T, Minami Y, Takahashi H, et al. (2019) Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion. Neurosurgical Review |
Kuwahara K, Ohba S, Nakae S, et al. (2019) Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Brain Tumor Pathology |
Pareira E, Ohara K, Shibuya M, et al. (2019) PATH-58. REAPPRAISAL OF HISTOLOGICAL FEATURES AND MOLECULAR ANALYSIS OF LOWER GRADE GLIOMAS AND ASSOCIATION WITH OVERALL SURVIVALS Neuro-Oncology. 21: vi156-vi156 |
Arita H, Matsushita Y, Ohno M, et al. (2019) PATH-37. PROGNOSTIC ROLE OF TERT PROMOTER MUTATIONS IMPROVES THE STRATIFICATION OF IDH-MUTATED LOWER GRADE GLIOMA Neuro-Oncology. 21: vi151-vi151 |